219 related articles for article (PubMed ID: 23113893)
21. Molecular basis of FIR-mediated c-myc transcriptional control.
Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
[TBL] [Abstract][Full Text] [Related]
22. The FBP interacting repressor targets TFIIH to inhibit activated transcription.
Liu J; He L; Collins I; Ge H; Libutti D; Li J; Egly JM; Levens D
Mol Cell; 2000 Feb; 5(2):331-41. PubMed ID: 10882074
[TBL] [Abstract][Full Text] [Related]
23. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
[TBL] [Abstract][Full Text] [Related]
24. A U2-snRNP-independent role of SF3b in promoting mRNA export.
Wang K; Yin C; Du X; Chen S; Wang J; Zhang L; Wang L; Yu Y; Chi B; Shi M; Wang C; Reed R; Zhou Y; Huang J; Cheng H
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7837-7846. PubMed ID: 30923118
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
[TBL] [Abstract][Full Text] [Related]
26. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
[TBL] [Abstract][Full Text] [Related]
27. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing.
Spadaccini R; Reidt U; Dybkov O; Will C; Frank R; Stier G; Corsini L; Wahl MC; Lührmann R; Sattler M
RNA; 2006 Mar; 12(3):410-25. PubMed ID: 16495236
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Ueda Y; Shimada H; Matsushita K; Shiotani A
PLoS One; 2015; 10(1):e0116279. PubMed ID: 25569246
[TBL] [Abstract][Full Text] [Related]
30. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
[TBL] [Abstract][Full Text] [Related]
31. Hfp, the Drosophila homolog of the mammalian c-myc transcriptional-repressor and tumor suppressor FIR, inhibits dmyc transcription and cell growth.
Cranna NJ; Mitchell NC; Hannan RD; Quinn LM
Fly (Austin); 2011; 5(2):129-33. PubMed ID: 21245665
[TBL] [Abstract][Full Text] [Related]
32. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition.
Izquierdo JM
J Biol Chem; 2008 Jul; 283(27):19077-84. PubMed ID: 18463097
[TBL] [Abstract][Full Text] [Related]
33. Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.
Tanaka N; Araki K; Mizokami D; Miyagawa Y; Yamashita T; Tomifuji M; Ueda Y; Inoue M; Matsushita K; Nomura F; Shimada H; Shiotani A
Gene Ther; 2015 Apr; 22(4):297-304. PubMed ID: 25588744
[TBL] [Abstract][Full Text] [Related]
34. Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors.
Thickman KR; Swenson MC; Kabogo JM; Gryczynski Z; Kielkopf CL
J Mol Biol; 2006 Feb; 356(3):664-83. PubMed ID: 16376933
[TBL] [Abstract][Full Text] [Related]
35. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
[TBL] [Abstract][Full Text] [Related]
36. The fission yeast prp10(+) gene involved in pre-mRNA splicing encodes a homologue of highly conserved splicing factor, SAP155.
Habara Y; Urushiyama S; Tani T; Ohshima Y
Nucleic Acids Res; 1998 Dec; 26(24):5662-9. PubMed ID: 9837997
[TBL] [Abstract][Full Text] [Related]
37. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells.
Müller B; Bovet M; Yin Y; Stichel D; Malz M; González-Vallinas M; Middleton A; Ehemann V; Schmitt J; Muley T; Meister M; Herpel E; Singer S; Warth A; Schirmacher P; Drasdo D; Matthäus F; Breuhahn K
J Pathol; 2015 Nov; 237(3):390-401. PubMed ID: 26177862
[TBL] [Abstract][Full Text] [Related]
38. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
[TBL] [Abstract][Full Text] [Related]
39. Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product.
Hasegawa M; Miura T; Kuzuya K; Inoue A; Won Ki S; Horinouchi S; Yoshida T; Kunoh T; Koseki K; Mino K; Sasaki R; Yoshida M; Mizukami T
ACS Chem Biol; 2011 Mar; 6(3):229-33. PubMed ID: 21138297
[TBL] [Abstract][Full Text] [Related]
40. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
Grohar PJ; Kim S; Rangel Rivera GO; Sen N; Haddock S; Harlow ML; Maloney NK; Zhu J; O'Neill M; Jones TL; Huppi K; Grandin M; Gehlhaus K; Klumpp-Thomas CA; Buehler E; Helman LJ; Martin SE; Caplen NJ
Cell Rep; 2016 Jan; 14(3):598-610. PubMed ID: 26776507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
